Use of composition for preventing, ameliorating or treating cognitive dysfunction comprising extract of polygonum cuspidatum root and cinnamomum cassia
US2021061854A1
Novel polymorphic forms of cyclo (-his-pro)
KR102133151B1
Composition comprising chp (cyclo-his pro) for preventing, improving or treating of peritoneal fibrosis
KR20210014541A
COMPOSITION COMPRISING EXTRACT OF POLYGONUM CUSPIDATUM SIEB. et ZUCC. AND CINNAMOMUM CASSIA BLUME FOR PREVENTING, IMPROVING OR TREATING OF BONE LOSS RELATED DISEASE
WO2020013974A1
Novel polymorphic forms of cyclo (-his-pro)
KR102115353B1
Composition comprising chp (cyclo-his pro) and pth for preventing, improving or treating of bone loss related disease
US2020345728A1
Compositions and methods for treatment of atherosclerosis
US2020338156A1
Composition comprising chp (cyclo-his pro) for preventing, improving or treating of bone loss related disease
KR20200053069A
Pharmaceutical composition for preventing or treating obesity comprising cyclo-hispro
CN111246859A
Pharmaceutical composition for preventing or treating diabetes containing zinc salt, cyclodipeptide-histidine proline and antidiabetic drug as effective component
KR20190092831A
Composition for preventing and improving woman climacterium symptoms comprising extract of Polygonum cuspidatum Sieb. et Zucc. and Cinnamomum cassia Blume
KR20190074746A
Pharmaceutical formulation for preventing or treating diabetes mellitus comprising cyclo-hispro
KR20190047359A
Anti-thrombus agent comprising extract of Polygonum cuspidatum Sieb. et Zucc. and Cinnamomum cassia Blume
KR20180018458A
Pharmaceutical composition for preventing or treating diabetes mellitus containing amodiaquine and antidiabetic drug
WO2018012901A1
Composition for cell protection containing cyclo histidine-proline as active ingredient
KR20180008305A
Cytoprotective composition for protection of cell containing Cyclo His-Pro as Active Ingredient
